Medicinal Chemistry

Short course

In Mayfield

Price on request

Description

  • Type

    Short course

  • Location

    Mayfield

At the end of the course, participants will have gained: An understanding of how biological disease targets are selected. An insight in to the terms, definitions and analysis methods used by medicinal. chemists in the pharmaceutical industry. An introductory knowledge of the Pharmacokinetics and ADME (Absorption, Distribution, Metabolism and Excretion) and how physicochemical properties influence absorption. An introduction to the use of computational chemistry including pharmacophore generation, virtual screening and library design. Suitable for: Young chemists who have just started in industry as medicinal chemists. Experienced medicinal chemists who wish to gain additional knowledge on how. to obtain compounds with optimal druglike properties and get up to date with the. latest thinking. Chemists from other areas of Research and Development who would like to gain. an appreciation of the processes and drivers involved in drug discovery. Students who are planning a career in industry and can obtain company sponsorship.

Facilities

Location

Start date

Mayfield (East Sussex)
See map
Maycroft Place, Stone Cross, TN20 6EW

Start date

On request

Questions & Answers

Add your question

Our advisors and other users will be able to reply to you

Who would you like to address this question to?

Fill in your details to get a reply

We will only publish your name and question

Reviews

Teachers and trainers (5)

Dr David Clark

Dr David Clark

Director of Computer-aided Drug Design (CADD) and Information Services

Dr David Clark is Director of Computer-aided Drug Design (CADD) and Information Services and was a founding scientific team member of Argenta Discovery in 2000. David began his career working for Proteus Molecular Design for 3 years where he was involved in developing software for de novo ligand design and protein-ligand docking. He then spent 4 years working in the CADD group of Aventis/Rhone-Poulenc Rorer before joining Argenta. David is a graduate of the University of Oxford where he studied chemistry. ...

Dr David Horwell

Dr David Horwell

London University

Dr David Horwell graduated from London University before undertaking his PhD in organic heterocyclic chemistry at Leicester University with Professor C W Rees, CBE, FRS. He then carried out post-doctoral research in Canada (National Research Council, Ottowa), Florida (Gainesville) and at Imperial College, London. This was followed by a research career in the pharmaceutical industry with Eli Lilly, Parke-David, Warner-Lambert and Pfizer. ...

Dr Geoff Lawton

Dr Geoff Lawton

Vice President Chemistry and Preclinical Sciences at Roche Bioscience

Dr Geoff Lawton was formerly the Vice President Chemistry and Preclinical Sciences at Roche Bioscience, Palo Alto, California and has extensive experience of new medicine discovery and early development. In 2001 he became an independent consultant in all aspects of drug discovery from target identification, through lead finding and optimisation to drug candidate selection and evaluation. He is currently Research Director at Lectus Therapeutics. ...

Dr Nigel Rogers

Dr Nigel Rogers

Director of Pre-clinical Science at Roche Discovery Welwyn

Dr Nigel Rogers was formerly Director of Pre-clinical Science at Roche Discovery Welwyn and was instrumental in introducing new early ADMET approaches to enable better selection and design of compounds in Lead Optimisation. Nigel has also extensive experience of the process from Lead Identification through to NDA filing with responsibilities including project management, regulatory affairs and leadership of several projects.

Dr Will Watson

Dr Will Watson

Scientific Update

Will Watson gained his PhD in Organic Chemistry from the University of Leeds in 1980. He joined the BP Research Centre at Sunbury-on-Thames and spent five and a half years working as a research chemist on a variety of topics including catalytic dewaxing, residue upgrading, synthesis of novel oxygenates for use as gasoline supplements, surfactants for use as gasoline detergent additives and non-linear optical compounds. ...

Course programme

Medicinal chemists need to understand the relationship between chemical structure and the physical properties of molecules and how this translates into compound stability and the interaction of the molecule with biological structures.
These biological targets include proteins, lipids, nucleic acids and cell membranes. Interaction of the molecules with these targets affects the distribution of the compound in biological systems and modulates biological function.
To do this successfully the medicinal chemist needs to be aware of how target selection is carried out and how this affects lead generation. The medicinal chemist needs knowledge of structure property relationships,
the physico-chemical properties of drugs and how these molecules interact with the body - pharmacokinetics and ADME (Absorption, Distribution, Metabolism and Excretion).
The course also includes an overview of the use of computational chemistry in virtual screening and library design. The lectures are backed up by a number of case studies and tutorial sessions, which involve the participants in using the concepts discussed.

Course Overview:

Introduction: Overview of drug discovery process,
target selection in the post-genomic era

Introduction to Medicinal Chemistry, definitions,
QSAR studies, drug receptors, Hansch Analysis,
physico-chemical properties, Topliss Tree

Physico-chemical properties of drugs

Implications for Absorption

Lead generation approaches

Lead generation using computational techniques:
molecular recognition, structure- and ligandbased virtual screening, success stories

Molecular diversity and combinatorial design

Pharmacokinetics and ADME with examples

Introduction to Lead Optimisation,

Case Studies

Overview of some of the reasons for project failure, of safety, in particular to its relationship to chemical structure and of critical issues in Drug Development.

Intellectual property issues related to drug discovery
What happens next? - a (very) brief overview of process development issues

Course Objectives:

At the end of the course, participants will have gained:

  • An understanding of how biological disease targets are selected.
  • An insight in to the terms, definitions and analysis methods used by medicinal chemists in the pharmaceutical industry.
  • An introductory knowledge of the Pharmacokinetics and ADME (Absorption, Distribution, Metabolism and Excretion) and how physicochemical properties influence absorption.
  • An introduction to the use of computational chemistry including pharmacophore generation, virtual screening and library design.
  • An overview of safety assessment and of chemical structure and safety.

Medicinal Chemistry

Price on request